FIP in Cats: The Disease That Changed When a Treatment Was Found

How a Common Cat Virus Becomes a Killer

Feline coronavirus (FCoV) is remarkably common -- an estimated 25-40% of household cats carry it, and in multi-cat homes or shelters, that figure rises to 80-90%. For most cats, FCoV causes mild diarrhea or no symptoms at all, and the virus eventually clears. In roughly 5-10% of infected cats, the virus mutates within the body and transforms into the FIP-causing strain. The mutation is random and unpredictable -- there is no test that identifies which cats will develop FIP, and no way to prevent the mutation itself.

The mutated virus evades the immune system by hiding inside macrophages (immune cells), traveling through the bloodstream, and triggering catastrophic inflammation around blood vessels. The result is one of two forms: wet (effusive) FIP, where fluid accumulates in body cavities, and dry (non-effusive) FIP, where granulomas form in organs, eyes, or the brain. Some cats present with both forms simultaneously.

Recognizing FIP Before It's Too Late

Wet FIP is often diagnosed when a cat suddenly develops a visibly swollen abdomen (ascites) or labored breathing (pleural effusion). The fluid is distinctive -- yellow, sticky, protein-rich, and it re-accumulates rapidly if drained. A cat that looks pregnant but hasn't been bred warrants immediate veterinary attention. Fever above 104F that doesn't respond to antibiotics over 5-7 days is a classic FIP red flag, often accompanied by weight loss and loss of appetite.

Dry FIP is harder to catch early. Signs depend on which organs are affected: jaundice (liver), vision changes or uveitis (eyes), rear leg weakness or seizures (spinal cord or brain), kidney failure signs (excessive thirst, vomiting). Neurological FIP, where the virus infiltrates the central nervous system, has historically been the hardest to treat and carries the lowest remission rates even with modern antivirals.

The Treatment That Changed Everything

Until 2019, FIP was a death sentence delivered within days to weeks of diagnosis. GS-441524, a nucleoside analog antiviral that blocks viral replication, changed that. In landmark studies by Dr. Niels Pedersen at UC Davis, GS-441524 achieved sustained remission in 85%+ of wet FIP cases treated for 84 days. Treatment courses run 12 weeks minimum, with some neurological cases requiring 16+ weeks. Drug costs run $200-$600 per month depending on the cat's weight and drug source, making total treatment costs typically $1,500-$4,000.

The drug is not yet FDA-approved in the US but is legally available through veterinarians via compounding pharmacies or imported from licensed manufacturers. An FDA-approved version, Xraphconn (ocivirza), received approval in late 2024 and is now available through veterinarians. If a vet mentions FIP diagnosis, ask specifically about GS-441524 or Xraphconn -- some general practitioners aren't current on the treatment options and may not offer them without prompting.

Monitoring Remission and What Comes After

Cats finishing a treatment course need bloodwork monitoring to confirm remission: normalization of albumin, globulin, and bilirubin, combined with resolution of symptoms and no fluid recurrence. Relapse occurs in 10-15% of cases and can typically be re-treated with an extended course. Cats in sustained remission for 12+ months after ending treatment are generally considered cured. They can live normal, full lives post-FIP.